Anhydrous crystalline forms of N- [1-(2-ethoxyethyl)-5-(N-ethyl-N-methyla mino)-7-(4-methylpyridin-2-yl-amino)-1 Hpyrazolo[4,3-d]pyrimidine-3-carbonyl]m ethanesulfonamide

Details for Australian Patent Application No. 2006245416 (hide)

Owner Pfizer Inc.

Inventors Entwistle, David Andrew; Taylor, Stefan Colin John; Marshall, Peter, Vallance

Agent Shelston IP

Pub. Number AU-B-2006245416

PCT Pub. Number WO2006/120552

Priority 60/681,711 17.05.05 US; 60/680,445 12.05.05 US

Filing date 3 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 23 February 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/120552 Priority application(s): WO2006/120552

23 February 2012 Application Accepted

  Published as AU-B-2006245416

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006245418-Herbicidal compositions

2006245411-Rotary electric device drive unit including the same